Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: A lost cause?
Authors
Lamarca, AngelaElliott, Emma
Barriuso, Jorge
Backen, Alison C
McNamara, Mairéad G
Hubner, Richard A
Valle, Juan W
Affiliation
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UKIssue Date
2016-01-25
Metadata
Show full item recordAbstract
Chemotherapy is well-established in the treatment of patients with well-differentiated neuroendocrine tumours (NETs) arising from the pancreas (pNETs); however, its role in patients with gastrointestinal non-pancreatic NETs (non-pNETs) is uncertain. This systematic review assesses the evidence for the role of chemotherapy in well-differentiated non-pNET patients.Citation
Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: A lost cause? 2016, 44:26-41 Cancer Treat RevJournal
Cancer Treatment ReviewsDOI
10.1016/j.ctrv.2016.01.005PubMed ID
26855376Type
ArticleLanguage
enISSN
1532-1967ae974a485f413a2113503eed53cd6c53
10.1016/j.ctrv.2016.01.005
Scopus Count
Collections
Related articles
- The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
- Authors: Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K
- Issue date: 2007 Nov
- Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.
- Authors: Franklin J, Eichenauer DA, Becker I, Monsef I, Engert A
- Issue date: 2017 Sep 13
- Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.
- Authors: Skoetz N, Will A, Monsef I, Brillant C, Engert A, von Tresckow B
- Issue date: 2017 May 25
- Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
- Authors: Abdel-Rahman O, Elsayed Z, Elhalawani H
- Issue date: 2018 Apr 6
- The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.
- Authors: Hind D, Tappenden P, Tumur I, Eggington S, Sutcliffe P, Ryan A
- Issue date: 2008 May